Current diagnostic and clinical issues of screening for dihydropyrimidine dehydrogenase deficiency-Reference-Cited by-同舟云学术

Current diagnostic and clinical issues of screening for dihydropyrimidine dehydrogenase deficiency

Published:2023-03 Issue: Volume:181 Page:3-17
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Etienne-Grimaldi Marie-Christine,Pallet Nicolas^ORCID,Boige Valérie,Ciccolini Joseph^ORCID,Chouchana Laurent^ORCID,Barin-Le Guellec Chantal,Zaanan Aziz,Narjoz Céline,Taieb Julien,Thomas Fabienne^ORCID,Loriot Marie-Anne

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference108 articles.

1. Toxicities associated with chemotherapy regimens containing a fluoropyrimidine: a real-life evaluation in France;Barin-Le Guellec;Eur J Cancer,2020

2. Clinical pharmacology of 5-fluorouracil;Diasio;Clin Pharmacokinet,1989

3. Capecitabine: fulfilling the promise of oral chemotherapy;Marshall;Expet Opin Pharmacother,2002

4. A rapid and inexpensive method for anticipating severe toxicity to fluorouracil and fluorouracil-based chemotherapy;Ciccolini;Ther Drug Monit,2006

5. Pathogenic DPYD variants and treatment-related mortality in patients receiving fluoropyrimidine chemotherapy: a systematic review and meta-analysis;Sharma;Oncol,2021

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of patients with reduced dihydropyrimidine dehydrogenase activity receiving combined 5-fluoruracil-/capecitabine-based chemoradiotherapy;Strahlentherapie und Onkologie;2024-09-04

2. Is uracil enough for effective pre-emptive DPD testing?;Clinical Chemistry and Laboratory Medicine (CCLM);2024-07-19

3. Can we identify patients carrying targeted deleterious DPYD variants with plasma uracil and dihydrouracil? A GPCO-RNPGx retrospective analysis;Clinical Chemistry and Laboratory Medicine (CCLM);2024-06-19

4. Lethal Capecitabine Toxicity in Patients With Complete Dihydropyrimidine Dehydrogenase Deficiency Due to Ultra-Rare DPYD Variants;JCO Precision Oncology;2024-05

5. Binding Pattern and Structural Interactome of the Anticancer Drug 5-Fluorouracil: A Critical Review;International Journal of Molecular Sciences;2024-03-17